StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Other Cardiovascular sub-franchise by Quarter

Other Cardiovascular sub-franchise — Worldwide reported growth YoY (%) (%)

QuarterlyAnnual

Johnson & Johnson Other Cardiovascular sub-franchise: -13.9% in Q3 2026, down 13.2 pts from a year earlier. That is the lowest of the 11 quarters on record here.

Latest, Q3 2026
-13.9%
Period ended Sep 30, 2026
Change on a year earlier
-13.2 pts
-0.7% in Q3 2025
History
11 quarters
Since Q1 2024
Sources
11
Documents cited below

Where the Q3 2026 figure comes from

“|| WW | 81 | 95 | (13.9) | (14.7) | 0.8”

Source: Form 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOther Cardiovascular sub-franchise — Worldwide reported growth YoY (%) (%)Year on yearSource
Q3 2026Sep 30, 2026-13.9%-13.2 ptsForm 8-K (a2026q3exhibit991.htm, filed 2026-10-13) ↗
Q2 2026Jun 28, 2026-5.7%-16.5 ptsForm 8-K (a2026q2exhibit991.htm, filed 2026-07-15) ↗
Q1 2026Mar 29, 2026-9.1%-21.6 ptsForm 8-K (a2026q1exhibit991.htm, filed 2026-04-14) ↗
Q4 2025Dec 28, 2025-4.6%-16.4 ptsForm 8-K (a2025q4exhibit991.htm, filed 2026-01-21) ↗
Q3 2025Sep 28, 2025-0.7%-11.1 ptsForm 8-K (a2025q3exhibit991.htm, filed 2025-10-14) ↗
Q2 2025Jun 29, 202510.8%+10.5 ptsForm 8-K (a2025q2exhibit991.htm, filed 2025-07-16) ↗
Q1 2025Mar 30, 202512.5%+6.8 ptsForm 8-K (a2025q1exhibit991.htm, filed 2025-04-15) ↗
Q4 2024Dec 29, 202411.8%–Form 8-K (a2024q4exhibit991.htm, filed 2025-01-22) ↗
Q3 2024Sep 29, 202410.4%–Form 8-K (a2024q3exhibit991.htm, filed 2024-10-15) ↗
Q2 2024Jun 30, 20240.3%–Form 8-K (a2024q2exhibit991.htm, filed 2024-07-17) ↗
Q1 2024Mar 31, 20245.7%–Form 8-K (a2024q1exhibit991.htm, filed 2024-04-16) ↗

Cite this data

StockData. (2026). Johnson & Johnson Other Cardiovascular sub-franchise (%), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-other-cv-rep-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.